Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.75 USD
Change Today +0.14 / 1.03%
Volume 311.3K
OME On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:04 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

omega protein corp (OME) Key Developments

Omega Protein Corporation Announces Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Omega Protein Corporation announced consolidated unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenues of $71,623,000 compared with $63,500,000 for the same period a year ago. Operating income was $3,660,000 compared with $12,346,000 for the same period a year ago. Income before income taxes was $2,647,000 compared with $12,051,000 for the same period a year ago. Net income was $1,669,000 or $0.08 per diluted share compared with $7,971,000 or $0.37 per diluted share for the same period a year ago. Net cash provided by operating activities was $3,797,000 compared with $21,035,000 for the same period a year ago. Capital expenditures was $10,560,000 compared with $12,815,000 for the same period a year ago. Adjusted income before income taxes was $4,166,000 compared with $13,621,000 for the same period a year ago. Adjusted net income was $2,627,000 or $0.12 per diluted share compared with $9,009,000 or $0.42 per diluted share for the same period a year ago. The increase in Revenue was due to growth in human nutrition revenues of $26.6 million, partially offset by a decline in animal nutrition revenues of $18.4 million. The increase in human nutrition Revenue was largely due to the addition of Bioriginal Food & Science Corp. ("Bioriginal"), which was acquired in September 2014. The decrease in animal nutrition Revenue was due to lower sales volumes of 76% and 12% for the Company's fish oil and fish meal, respectively, partially offset by increased sales prices of 56% and 6% for the Company's fish oil and fish meal, respectively. The composition of revenues by nutritional product line for the first quarter of 2015 was 49% dietary supplements and food, 37% fish meal, 13% fish oil and 1% fish solubles and other.

Omega Protein Corporation Presents at BMO Capital Markets 10th Annual Farm to Market Conference 2015, May-20-2015 01:30 PM

Omega Protein Corporation Presents at BMO Capital Markets 10th Annual Farm to Market Conference 2015, May-20-2015 01:30 PM. Venue: Grand Hyatt New York, New York, New York, United States. Speakers: Andrew C. Johannesen, Chief Financial Officer and Executive Vice President.

Omega Protein Corporation to Report Q1, 2015 Results on May 11, 2015

Omega Protein Corporation announced that they will report Q1, 2015 results at 5:00 PM, Eastern Standard Time on May 11, 2015

Omega Protein Corporation, Q1 2015 Earnings Call, May 12, 2015

Omega Protein Corporation, Q1 2015 Earnings Call, May 12, 2015

Omega Protein Corporation Reports Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2014; Reports Impairment of Goodwill and Other Tangible Assets for the Fourth Quarter Ended December 31, 2014

Omega Protein Corporation reported consolidated earnings results for the fourth quarter and full year ended December 31, 2014. For the quarter, the company reported revenues of $102,458,000 against $65,973,000 a year ago. This increase was due to growth in animal nutrition revenues of $11.5 million and human nutrition revenues of $25.0 million. Operating income was $6,689,000 against $14,679,000 a year ago. Income before income taxes was $5,981,000 against $14,271,000 a year ago. Net income was $3,198,000 against $9,718,000 a year ago. Diluted earnings per share were $0.14 against $0.45 per share a year ago. Capital expenditures were $7,869,000 against $6,787,000 a year ago. Adjusted EBITDA was $19,863,000 against $26,716,000 a year ago. Adjusted net income was $7,792,000 or $0.35 per diluted share against $14,311,000 or $0.67 per share a year ago. For the year, the company reported revenues of $308,635,000 against $244,293,000 a year ago. Operating income was $31,586,000 against $48,013,000 a year ago. The increase in Revenue was due to a $30.6 million increase in animal nutrition revenues and a $33.8 million increase in human nutrition revenues. Income before income taxes was $30,207,000 against $45,979,000 a year ago. Net income was $18,461,000 against $30,515,000 a year ago. Diluted earnings per share were $0.85 against $1.45 per share a year ago. Net cash provided by operating activities was $64,922,000 against $32,020,000 a year ago. Capital expenditures were $44,123,000 against $24,796,000 a year ago. Adjusted EBITDA was $70,124,000 against $76,552,000 a year ago. Adjusted net income was $29,908,000 or $1.37 per diluted share against $35,813,000 or $1.70 per share a year ago The company reported impairment of goodwill and other tangible assets for the fourth quarter of $4,718,000 against $186,000 a year ago. Impairment increased $0.2 million due to impairment expenses related to the InCon and Cyvex reporting unit within the human nutrition segment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OME:US $13.75 USD +0.14

OME Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Archer-Daniels-Midland Co $52.85 USD +0.19
ConAgra Foods Inc $38.61 USD -0.09
Wal-Mart Stores Inc $74.27 USD -0.57
View Industry Companies
 

Industry Analysis

OME

Industry Average

Valuation OME Industry Range
Price/Earnings 24.6x
Price/Sales 0.9x
Price/Book 1.1x
Price/Cash Flow 24.3x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMEGA PROTEIN CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.